Contact

All Stories

  1. Dysregulated Fas/Fas ligand expression in endometrial stromal cells and mononuclear cells in endometriosis

    Article • Scientific Reports, June 2026, Springer Science + Business Media

    Pooya Farhangnia

  2. Increased circulating T helper 17 (TH17) cells and endometrial tissue IL-17-producing cells in patients with endometriosis compared with non-endometriotic subjects

    Article • Reproductive Biology, June 2025, Elsevier

    Pooya Farhangnia

  3. Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies

    Article • International Journal of Biological Macromolecules, April 2025, Elsevier

    Pooya Farhangnia

  4. Bispecific Antibodies in Targeted Cancer Immunotherapy

    Article • January 2025, Springer Science + Business Media

    Pooya Farhangnia

  5. The Role of Inflammasome in Cancers and Potential Therapeutic Targets

    Article • January 2025, Springer Science + Business Media

    Pooya Farhangnia

  6. Identification of placenta-specific protein 1 (PLAC-1) expression on human PC-3 cell line-derived prostate cancer stem cells compared to the tumor parental cells

    Article • Discover Oncology, June 2024, Springer Science + Business Media

    Pooya Farhangnia

  7. Current and future immunotherapeutic approaches in pancreatic cancer treatment

    Article • Journal of Hematology & Oncology, June 2024, Springer Science + Business Media

    Pooya Farhangnia

  8. Vitamin D and reproductive disorders: a comprehensive review with a focus on endometriosis

    Article • Reproductive Health, May 2024, Springer Science + Business Media

    Pooya Farhangnia

  9. Unraveling the potential of CD8, CD68, and VISTA as diagnostic and prognostic markers in patients with pancreatic ductal adenocarcinoma

    Article • Frontiers in Immunology, January 2024, Frontiers

    Pooya Farhangnia

  10. Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances

    Article • January 2024, Springer Science + Business Media

    Pooya Farhangnia

  11. The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-bli...

    Article • Phytomedicine, December 2023, Elsevier

    Pooya Farhangnia

  12. Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial

    Article • Frontiers in Nutrition, September 2023, Frontiers

    Pooya Farhangnia

  13. One pediatrician's battle with COVID-19 and acute liver failure

    Article • Journal of Clinical Virology Plus, August 2023, Elsevier

    Pooya Farhangnia

  14. Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy

    Article • Frontiers in Immunology, June 2023, Frontiers

    Pooya Farhangnia

  15. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

    Article • Frontiers in Immunology, May 2023, Frontiers

    Pooya Farhangnia

  16. The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma

    Article • Cancer Treatment and Research Communications, January 2023, Elsevier

    Pooya Farhangnia

  17. Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells

    Article • January 2023, Springer Science + Business Media

    Pooya Farhangnia

  18. Bispecific Antibodies in Targeted Cancer Immunotherapy

    Article • January 2023, Springer Science + Business Media

    Pooya Farhangnia

  19. Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment

    Article • January 2023, Springer Science + Business Media

    Pooya Farhangnia

  20. The Role of Inflammasome in Cancers and Potential Therapeutic Targets

    Article • January 2023, Springer Science + Business Media

    Pooya Farhangnia

  21. Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors

    Article • January 2023, Springer Science + Business Media

    Pooya Farhangnia

  22. Complement system as the potential therapeutic target in the management of COVID-19 patients

    Article • Trends in Immunotherapy, December 2022, UK Scientific Publishing Limited

    Pooya Farhangnia

  23. Tumor-promoting myeloid cells in the pathogenesis of human oncoviruses: potential targets for immunotherapy

    Article • Cancer Cell International, October 2022, Springer Science + Business Media

    Pooya Farhangnia

  24. Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives

    Article • Expert Review of Clinical Immunology, September 2022, Taylor & Francis

    Pooya Farhangnia

  25. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials

    Article • International Immunopharmacology, August 2022, Elsevier

    Pooya Farhangnia

  26. Body mass index and endometriosis: Is there a relationship?

    Article • Journal of Endometriosis and Pelvic Pain Disorders, April 2022, SAGE Publications

    DR. sepideh khodaverdi, Pooya Farhangnia

  27. Acute Liver Failure in a Pediatrician with COVID-19: a Case Report

    Article • March 2022, Wiley

    Pooya Farhangnia

  28. The Role of Intra-Tumor Hypoxia in Cancer Cells Immune Escape Mechanism

    Article • January 2022, Springer Science + Business Media

    Pooya Farhangnia

  29. Immunological Tolerance

    Article • January 2022, Elsevier

    Pooya Farhangnia

  30. The molecular mechanisms and therapeutic potential of EZH2 in breast cancer

    Article • Life Sciences, December 2021, Elsevier

    Pooya Farhangnia

  31. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV

    Article • January 2021, Springer Science + Business Media

    Pooya Farhangnia

  32. Death due to COVID‐19 in a patient with diabetes, epilepsy, and gout comorbidities

    Article • Clinical Case Reports, November 2020, Wiley

    Pooya Farhangnia

  33. Death due to Covid-19 in a Patient with Diabetes, Epilepsy, and Gout comorbidities

    Article • September 2020, Wiley

    Pooya Farhangnia